Marissa Mederos Benge, NP

Offices

6 locations · University of California San Francisco · UCSF Medical Group Business Services

Looking this up.

Hospitals listed: California Pacific Medical Center- Van Ness Campus · UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

3 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Marissa Mederos Benge’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Sort by

Plans whose provider directory lists this clinician

Imperial Courage Plan (HMO)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026
Imperial Dynamic Plan (HMO)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026
Imperial Senior Value (HMO C-SNP)	Imperial Health Plan of California, Inc.	Listed	Sep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at California Pacific Medical Center- Van Ness Campus

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.224	Better	Oct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.325	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.373	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.14 (0.3 to 1.97) · 2,271 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.05 (0.81 to 1.28)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	192.86 (151.51 to 234.22) · 140 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.6 · 55 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	10.3 · 60 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10.5 · 143 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9.8 · 356 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.3 · 259 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	10.1 · 173 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	3.1 · 2,316 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.31 (0.12 to 0.49) · 6,430 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.09 to 0.47) · 7,168 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.3 (1.5 to 5.09) · 2,196 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	2.47 (1.21 to 3.74) · 925 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.63 (1.37 to 3.88) · 1,954 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	10.13 (6.06 to 14.2) · 1,112 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	7.26 (4.67 to 9.85) · 1,084 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.67 (0.31 to 3.03) · 832 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.33 (0 to 0.85) · 5,406 cases	No different	Jul 2022 – Jun 2024
MRSA BacteremiaInfections	0.443	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.717	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 200 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	22.3 · 449 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	18.2 · 187 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	8.7 · 418 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	7.1 · 260 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	19.2 · 293 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (3.6 to 7.6) · 157 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	10.2 (7.7 to 13.5) · 157 cases	No different	Jan 2024 – Dec 2024
Rate of readmission for CABGUnplanned return visits	11 · 33 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.2 · 66 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.5 (9.4 to 16.7) · 551 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.3) · 219 cases	No different	Jan 2024 – Dec 2024

What patients said (478 patients answered, 20% of those asked)

Sort by

Patient survey stars by topic at California Pacific Medical Center- Van Ness Campus

Cleanliness	4
Nurse communication	3
Doctor communication	3
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at California Pacific Medical Center- Van Ness Campus

Room was "always" clean	75%
Nurses "always" communicated well	74%
Doctors "always" communicated well	77%
Staff "always" explained	59%
Yes, staff "did" give patients this information	88%
Yes, staff "did" give patients information about help after discharge	88%
Doctors "always" explained things so they could understand	71%
Doctors "always" listened carefully	75%
Doctors "always" treated them with courtesy and respect	85%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	75%
Nurses "always" explained things so they could understand	70%
Nurses "always" listened carefully	71%
Nurses "always" treated them with courtesy and respect	82%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	88%

See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at UCSF Medical Center

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	4.9 (3.79 to 6.02) · 7,590 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	12.8 (11.3 to 14.4) · 2,019 cases	Worse	Jan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	139.4 (110.22 to 168.58) · 452 cases	Better	Jul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.622	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.626	Better	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.491	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.8 (0.7 to 1) · 2,336 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.24 (0.58 to 1.9) · 4,689 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	1.05 (0.89 to 1.2)	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.9 · 89 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.5 · 85 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10.1 · 132 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.6 · 454 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 618 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.6 · 380 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.7 · 5,000 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.22 (0.06 to 0.38) · 15,965 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.2 (0.05 to 0.35) · 17,859 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.85 (0 to 1.83) · 4,184 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2 (1.1 to 2.9) · 6,516 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.35 (4.49 to 10.21) · 3,989 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5 (3.22 to 6.77) · 4,087 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.95 (0.74 to 3.15) · 2,034 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.95 (0.63 to 1.28) · 15,431 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	4 · 399 cases	None	Apr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.899	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.689	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	1.224	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16 · 156 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20 · 564 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	60.3 · 160 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-9.7 · 550 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	44.1 · 660 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.8 · 667 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.7 (4.8 to 6.7) · 2,019 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	6 · 421 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	10.5 · 53 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20 · 107 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13.9 (11.3 to 17.1) · 3,247 cases	No different	Jan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at UCSF Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at UCSF Medical Center

Room was "always" clean	71%
Nurses "always" communicated well	80%
Doctors "always" communicated well	80%
Staff "always" explained	61%
Yes, staff "did" give patients this information	88%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	78%
Doctors "always" treated them with courtesy and respect	86%
Patients who gave a rating of "9" or "10" (high)	76%
Staff "always" explained new medications	75%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	78%
Nurses "always" treated them with courtesy and respect	86%
"Always" quiet at night	50%
"YES", patients would definitely recommend the hospital	81%
Staff "always" explained possible side effects	46%
Yes, staff "did" give patients information about possible symptoms	90%

Drugs they prescribed that Part D paid

$216,079

Pharmacies billed $216,079 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 2,089) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.

1,769 generic and fewer than 11 brand-name prescriptions · $216,079 in drug cost · 108 antibiotic prescriptions to 74 people · 12 antipsychotic prescriptions to people over 65.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Eliquis	54	$44,536	$825
Jardiance	24	$22,320	$930
Ozempic	19	$21,706	$1,142
Rybelsus	13	$17,333	$1,333
Trelegy Ellipta	17	$16,787	$987

See all 47 drugs

Sort by

Every Part D drug this clinician prescribed

Eliquis	54	$44,536	$825
Jardiance	24	$22,320	$930
Ozempic	19	$21,706	$1,142
Rybelsus	13	$17,333	$1,333
Trelegy Ellipta	17	$16,787	$987
Wegovy	12	$16,554	$1,379
Atorvastatin	262	$3,108	$12
Ursodiol	20	$1,573	$79
Levothyroxine	118	$1,315	$11
Losartan	96	$1,293	$13
Lisinopril	134	$1,003	$7
Alendronate	18	$914	$51
Amlodipine Besylate	108	$830	$8
Rosuvastatin	44	$775	$18
Ezetimibe	23	$727	$32
Metformin	39	$718	$18
Metoprolol	32	$712	$22
Gabapentin	52	$702	$14
Synthroid	14	$609	$44
Naltrexone	19	$515	$27
Pravastatin	45	$445	$10
Benazepril	13	$383	$29
Escitalopram	36	$374	$10
Olmesartan Medoxomil	19	$359	$19
Albuterol Sulfate Hfa	23	$351	$15
Valacyclovir	22	$317	$14
Chlorthalidone	16	$246	$15
Pantoprazole	17	$231	$14
Doxycycline Hyclate	23	$227	$10
Glipizide Er	16	$221	$14
Simvastatin	30	$219	$7
Allopurinol	16	$218	$14
Nitrofurantoin Mono-Macro	14	$192	$14
Atenolol	12	$188	$16
Fluticasone Propionate	18	$166	$9
Furosemide	15	$158	$11
Sertraline	20	$141	$7
Trazodone	15	$136	$9
Metoprolol	16	$133	$8
Hydrochlorothiazide	33	$107	$3
Amoxicillin-Clavulanate Potass	14	$87	$6
Omeprazole	14	$87	$6
Sulfamethoxazole-Trimethoprim	19	$57	$3
Azithromycin	13	$50	$4
Quetiapine	12	$44	$4
Cephalexin	11	$43	$4
Paxlovid	17	$0	$0

Year by year

Sort by

Part D prescribing by year

2024	2,089	377	0% (0)	None	$216,079
2023	1,600	350	0% (0)	12%	$105,682
2022	1,769	400	None	14%	$132,448
2021	1,347	295	None	None	$81,770
2020	977	209	None	None	$48,146
2019	1,543	319	1% (11)	None	$108,090
2018	1,091	279	None	None	$51,800
2017	434	167	None	20%	$16,609

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 34 drugs

Sort by

Part D drugs prescribed in 2023

Eliquis	14	$13,554	$968
Atorvastatin	199	$2,445	$12
Ursodiol	15	$2,051	$137
Levothyroxine	98	$1,424	$15
Rosuvastatin	35	$1,176	$34
Metoprolol	33	$1,169	$35
Losartan	77	$1,034	$13
Lisinopril	103	$986	$10
Synthroid	23	$859	$37
Amlodipine Besylate	87	$837	$10
Valacyclovir	21	$738	$35
Albuterol Sulfate Hfa	22	$630	$29
Chlorthalidone	19	$525	$28
Allopurinol	26	$486	$19
Metformin	44	$485	$11
Gabapentin	38	$450	$12
Venlafaxine Hcl Er	12	$444	$37
Pravastatin	38	$354	$9
Alendronate	23	$275	$12
Atenolol	12	$274	$23
Sertraline	29	$219	$8
Metformin Hcl Er	13	$219	$17
Paxlovid (Eua)	20	$211	$11
Fluticasone Propionate	15	$185	$12
Nystatin	11	$180	$16
Hydrochlorothiazide	33	$179	$5
Simvastatin	24	$169	$7
Escitalopram	19	$154	$8
Citalopram Hbr	20	$146	$7
Nitrofurantoin Mono-Macro	11	$120	$11
Metoprolol	11	$111	$10
Triamcinolone Acetonide	17	$92	$5
Sulfamethoxazole-Trimethoprim	16	$55	$3
Azithromycin	12	$42	$3

2022: 39 drugs

Sort by

Part D drugs prescribed in 2022

Jardiance	41	$27,847	$679
Eliquis	24	$21,300	$887
Atorvastatin	209	$2,700	$13
Levothyroxine	96	$1,670	$17
Losartan	94	$1,605	$17
Lisinopril	120	$1,209	$10
Metoprolol	34	$1,008	$30
Synthroid	17	$967	$57
Valacyclovir	18	$902	$50
Rosuvastatin	37	$842	$23
Albuterol Sulfate Hfa	24	$836	$35
Metformin	70	$822	$12
Amlodipine Besylate	94	$686	$7
Chlorthalidone	22	$648	$29
Pravastatin	36	$646	$18
Fluoxetine	16	$628	$39
Gabapentin	48	$620	$13
Allopurinol	26	$461	$18
Citalopram Hbr	30	$439	$15
Duloxetine	12	$413	$34
Pantoprazole	17	$316	$19
Benazepril	18	$315	$18
Simvastatin	21	$315	$15
Tamsulosin	15	$309	$21
Escitalopram	25	$301	$12
Fluticasone Propionate	11	$277	$25
Alendronate	25	$274	$11
Atenolol	16	$261	$16
Nitrofurantoin Mono-Macro	13	$250	$19
Paxlovid (Eua)	18	$193	$11
Metoprolol	17	$174	$10
Bupropion Xl	14	$166	$12
Mirtazapine	13	$163	$13
Hydrochlorothiazide	42	$132	$3
Triamcinolone Acetonide	18	$109	$6
Baclofen	12	$106	$9
Omeprazole	13	$87	$7
Azithromycin	13	$75	$6
Sulfamethoxazole-Trimethoprim	12	$45	$4

2021: 26 drugs

Sort by

Part D drugs prescribed in 2021

Eliquis	20	$17,900	$895
Ursodiol	22	$3,089	$140
Atorvastatin	143	$2,321	$16
Levothyroxine	83	$1,643	$20
Metoprolol	33	$1,181	$36
Losartan	86	$1,135	$13
Duloxetine	16	$949	$59
Albuterol Sulfate Hfa	25	$919	$37
Chlorthalidone	18	$809	$45
Lisinopril	86	$736	$9
Metformin	67	$559	$8
Gabapentin	35	$509	$15
Amlodipine Besylate	82	$488	$6
Rosuvastatin	17	$470	$28
Pantoprazole	12	$465	$39
Pravastatin	21	$277	$13
Mirtazapine	14	$261	$19
Atenolol	19	$260	$14
Allopurinol	18	$243	$14
Simvastatin	18	$219	$12
Alendronate	11	$170	$15
Citalopram Hbr	19	$165	$9
Hydrochlorothiazide	32	$143	$4
Fluoxetine	12	$112	$9
Amoxicillin-Clavulanate Potass	13	$110	$8
Sulfamethoxazole-Trimethoprim	12	$43	$4

2020: 21 drugs

Sort by

Part D drugs prescribed in 2020

Eliquis	11	$5,669	$515
Atorvastatin	109	$2,587	$24
Levothyroxine	64	$1,500	$23
Metoprolol	21	$868	$41
Lisinopril	73	$698	$10
Losartan	41	$674	$16
Chlorthalidone	12	$579	$48
Pantoprazole	17	$473	$28
Gabapentin	31	$469	$15
Venlafaxine Hcl Er	21	$454	$22
Mirtazapine	14	$324	$23
Bupropion Xl	14	$313	$22
Metformin	51	$308	$6
Amitriptyline	13	$280	$22
Trazodone	19	$280	$15
Amlodipine Besylate	32	$272	$9
Pravastatin	15	$243	$16
Atenolol	15	$205	$14
Simvastatin	12	$151	$13
Hydrochlorothiazide	19	$146	$8
Allopurinol	16	$138	$9

2019: 41 drugs

Sort by

Part D drugs prescribed in 2019

Eliquis	17	$9,990	$588
Entresto	11	$5,989	$544
Ursodiol	15	$3,426	$228
Atorvastatin	125	$3,415	$27
Levothyroxine	117	$2,522	$22
Metoprolol	22	$1,145	$52
Proair Hfa	14	$941	$67
Lisinopril	96	$769	$8
Gabapentin	45	$612	$14
Synthroid	14	$539	$39
Pravastatin	28	$505	$18
Fluoxetine	15	$498	$33
Azelastine	11	$477	$43
Losartan	49	$471	$10
Amlodipine Besylate	56	$431	$8
Mirtazapine	17	$424	$25
Venlafaxine Hcl Er	30	$413	$14
Bupropion Xl	19	$386	$20
Nystatin	14	$371	$26
Doxycycline Hyclate	11	$357	$32
Simvastatin	25	$354	$14
Metformin	51	$329	$6
Allopurinol	36	$310	$9
Escitalopram	25	$287	$11
Trazodone	19	$287	$15
Benazepril	14	$281	$20
Alendronate	22	$276	$13
Azithromycin	32	$255	$8
Amitriptyline	11	$233	$21
Montelukast	18	$213	$12
Pantoprazole	23	$212	$9
Fluticasone Propionate	14	$205	$15
Nitrofurantoin Mono-Macro	13	$205	$16
Atenolol	19	$174	$9
Amoxicillin-Clavulanate Potass	15	$155	$10
Duloxetine	11	$129	$12
Triamcinolone Acetonide	17	$116	$7
Metoprolol	11	$112	$10
Hydrochlorothiazide	18	$107	$6
Sulfamethoxazole-Trimethoprim	16	$90	$6
Paroxetine	13	$82	$6

2018: 26 drugs

Sort by

Part D drugs prescribed in 2018

Atorvastatin	89	$2,527	$28
Levothyroxine	74	$2,127	$29
Proair Hfa	14	$875	$62
Rosuvastatin	12	$852	$71
Synthroid	20	$701	$35
Ventolin Hfa	12	$662	$55
Metoprolol	12	$557	$46
Amitriptyline	15	$460	$31
Amlodipine Besylate	49	$430	$9
Losartan	47	$423	$9
Gabapentin	26	$420	$16
Lisinopril	68	$403	$6
Allopurinol	20	$285	$14
Montelukast	17	$274	$16
Amoxicillin-Clavulanate Potass	20	$231	$12
Azithromycin	29	$229	$8
Metoprolol	15	$227	$15
Simvastatin	24	$221	$9
Nitrofurantoin Mono-Macro	11	$178	$16
Doxycycline Hyclate	11	$149	$14
Venlafaxine Hcl Er	18	$142	$8
Benazepril	12	$138	$12
Metformin	19	$121	$6
Hydrochlorothiazide	12	$112	$9
Atenolol	15	$91	$6
Zolpidem	13	$61	$5

2017: 10 drugs

Sort by

Part D drugs prescribed in 2017

Levothyroxine	28	$769	$27
Atorvastatin	21	$732	$35
Ventolin Hfa	11	$586	$53
Fluticasone Propionate	17	$295	$17
Amoxicillin-Clavulanate Potass	17	$221	$13
Azithromycin	23	$166	$7
Losartan	23	$147	$6
Simvastatin	11	$52	$5
Lisinopril	11	$43	$4
Hydrochlorothiazide	13	$24	$2

Money from drug and device companies

$154 in 2025

Sort by

Industry payments by year

2025	4	6	None	$154
2024	13	20	None	$608
2023	3	3	None	$73
2021	2	5	None	$97

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Pfizer	Paxlovid	$65	3 payments Meals for Paxlovid · 2025-06-25 · $24 Meals for Eliquis · 2025-03-26 · $24 Meals for Paxlovid · 2025-02-03 · $17
E.R. Squibb & Sons L.L.C.	Camzyos	$36	1 payment Meals for Camzyos · 2025-03-12 · $36
Bayer Healthcare Pharmaceuticals	Adempas	$31	1 payment Meals for Adempas · 2025-01-05 · $31
Novartis Pharmaceuticals	Leqvio	$21	1 payment Meals for Leqvio · 2025-03-05 · $21

See all 6 published payments

Sort by

Every published payment

Pfizer	Meals · 2025-06-25	Paxlovid	$24
Pfizer	Meals · 2025-03-26	Eliquis	$24
E.R. Squibb & Sons L.L.C.	Meals · 2025-03-12	Camzyos	$36
Novartis Pharmaceuticals	Meals · 2025-03-05	Leqvio	$21
Pfizer	Meals · 2025-02-03	Paxlovid	$17
Bayer Healthcare Pharmaceuticals	Meals · 2025-01-05	Adempas	$31

See earlier years (2024, 2023, 2021)

2024: $608

Sort by

Payments by company in 2024

Lexicon Pharmaceuticals	Inpefa	$124	1 payment Meals for Inpefa · 2024-02-21 · $124
Novo Nordisk	Ozempic	$102	5 payments Meals for Rybelsus · 2024-04-05 · $25 Meals for Ozempic · 2024-03-11 · $14 Meals for Ozempic · 2024-01-31 · $25 Meals · 2024-01-30 · $19 Meals for Ozempic · 2024-01-06 · $20
Pfizer	Eliquis	$63	2 payments Meals for Prevnar 20 · 2024-09-12 · $29 Meals for Eliquis · 2024-02-22 · $34
Bayer Healthcare Pharmaceuticals	Kerendia	$63	2 payments Meals for Kerendia · 2024-11-13 · $33 Meals for Adempas · 2024-10-16 · $30
AstraZeneca Pharmaceuticals LP	Breztri	$39	2 payments Meals for Airsupra · 2024-05-07 · $18 Meals for Breztri · 2024-02-17 · $21
Atricure	Epi-Sense Guided Coagulation System With Visitrax	$37	1 payment Meals for Epi-Sense Guided Coagulation System With Visitrax · 2024-10-22 · $37
GlaxoSmithKline	Trelegy Ellipta	$30	1 payment Meals for Trelegy Ellipta · 2024-03-27 · $30
Amgen	Repatha	$29	1 payment Meals for Repatha · 2024-10-30 · $29
Actelion Pharmaceuticals US	Uptravi	$28	1 payment Meals for Uptravi · 2024-09-24 · $28
Merck Sharp & Dohme	Verquvo	$28	1 payment Meals for Verquvo · 2024-08-28 · $28
Kiniksa Pharmaceuticals International plc	Arcalyst	$24	1 payment Meals for Arcalyst · 2024-09-04 · $24
Lilly USA	Mounjaro	$24	1 payment Meals for Mounjaro · 2024-05-03 · $24
iRhythm Technologies	Zio Xt Patch	$18	1 payment Meals for Zio Xt Patch · 2024-10-02 · $18

2023: $73

Sort by

Payments by company in 2023

GlaxoSmithKline	Trelegy Ellipta	$28	1 payment Meals for Trelegy Ellipta · 2023-12-14 · $28
Lexicon Pharmaceuticals	Inpefa	$25	1 payment Meals for Inpefa · 2023-11-14 · $25
Novo Nordisk	Rybelsus	$20	1 payment Meals for Rybelsus · 2023-11-03 · $20

2021: $97

Sort by

Payments by company in 2021

AstraZeneca Pharmaceuticals LP	Breztri	$80	4 payments Meals for Breztri · 2021-10-27 · $23 Meals for Breztri · 2021-07-30 · $18 Meals for Breztri · 2021-06-05 · $22 Meals for Breztri · 2021-03-27 · $18
Lilly USA	Trulicity	$16	1 payment Meals for Trulicity · 2021-04-16 · $16

Checkups this office reported

2023

Medicare did not publish checkup rates for this clinician.

What the office says it does

Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.

Implementation of medication management practice improvements
Improved the patient portal
Lets patients read their visit notes
Uses standard treatment protocols

Professional record

NPI: 1225483860
Licence: CA 95004182
Group: University of California San Francisco · UCSF Medical Group Business Services
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 363LF0000X (363LF0000X)
Mailing address: 3638 24th St, Apt 2, San Francisco, CA, 94110
NPI first listed: 2016-05-02
NPI last updated: 2017-05-07

This is when the NPI record was last certified, not a medical board exam.